Hormone Therapy News

Among menopausal women, hormone therapy use and duration were not associated with brain malignancy risk, although researchers cautioned that more research is needed, according to findings published in Menopause.

The FDA has recommended several labeling changes to all approved testosterone replacement therapy products based on the agency’s review of several studies, according to a release.

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Donna Shoupe, MD, about the health benefits of menopausal hormone therapy for women.

A woman’s risk for blood clots varied by the type of hormonal contraception used, according to a nationwide cohort study conducted in Denmark.

Published results showed women who used systemic hormonal contraceptives, such as pills, patches, implants, injections and rings, had decreased incidences of ACL injuries vs. women who were not using contraceptives.

Recently postmenopausal women with elevated blood pressure but no other CVD risk factors were more likely to develop white matter lesions 14 years later, regardless of short-term hormone therapy use, data show.

Growing interest in male contraceptive options in the wake of the Dobbs decision and current abortion laws have spurred increased attention in development of a transdermal gel for men to block sperm production.

Use of menopausal hormone therapy among midlife active-duty servicewomen in the U.S. is twice as high as the general population but lower than women veterans, suggesting those who may derive the most benefit from HT are not receiving it.

Less than 0.1% of adolescents in the United States identified as transgender or gender diverse and received puberty blockers or gender-affirming hormones, according to study findings published this week in JAMA Pediatrics.